The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥ 50%: EMPOWER-Lung 1 subgroup analysis.
 
Mustafa Ozguroglu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Ahmet Sezer
Honoraria - Amgen (Inst); pfizer (Inst); Roche (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Pfizer; Roche
Research Funding - Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Saadettin Kilickap
Consulting or Advisory Role - MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Speakers' Bureau - MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
 
Mahmut Gumus
Honoraria - MSD Oncology (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Lilly (Inst); Novartis (Inst); Roche
Speakers' Bureau - MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Igor Bondarenko
No Relationships to Disclose
 
Miranda Gogishvili
No Relationships to Disclose
 
Haci M. Turk
No Relationships to Disclose
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Dmitry Bentsion
No Relationships to Disclose
 
Oleg Gladkov
No Relationships to Disclose
 
Philip R. Clingan
No Relationships to Disclose
 
Virote Sriuranpong
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Naiyer A. Rizvi
Stock and Other Ownership Interests - Arcus Biosciences; Bellicum Pharmaceuticals; Brooklyn ImmunoTherapeutics; Gritstone Bio
Consulting or Advisory Role - Abbvie; Abbvie; Apricity Health; Arcus Biosciences; AstraZeneca/MedImmune; Bellicum Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Editas Medicine; EMD Serono; Genentech/Roche; GlaxoSmithKline; Illumina; Janssen; Lilly; Merck Sharp & Dohme; NeoGenomics Laboratories; Novartis; Regeneron; Takeda
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - Royalties related to patent filed by MSKCC, Determinants of cancer response to immunotherapy (PCT/US2015/062208) licensed to Personal Genome Diagnostics
 
Jennifer McGinniss
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jean-Francois Pouliot
No Relationships to Disclose
 
Sue Lee
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Frank A. Seebach
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Giuseppe Gullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Petra Rietschel
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron